Tag: AI in trials

Technology Adoption Curves (AI, DCT, eSource): What Clinical Leaders Need to Know Now In the dynamic landscape of clinical research and trials, technology adoption is critical. As clinical leaders navigate the complexities of clinical trial design and execution, challenges and opportunities emerge. With a focus on Artificial Intelligence (AI), Decentralized Trials (DCT), and eSource technologies,…

Read More “Technology Adoption Curves (AI, DCT, eSource): What Clinical Leaders Need to Know Now” »

How to Model Technology Adoption Curves (AI, DCT, eSource) for Global Study Portfolios How to Model Technology Adoption Curves (AI, DCT, eSource) for Global Study Portfolios The evolution of technology within the clinical trial landscape has necessitated a systematic approach to understanding technology adoption curves. This article provides a step-by-step tutorial for clinical operations, regulatory…

Read More “How to Model Technology Adoption Curves (AI, DCT, eSource) for Global Study Portfolios” »

Technology Adoption Curves (AI, DCT, eSource) in Practice: Benchmarks, Case Studies and Playbooks Technology Adoption Curves (AI, DCT, eSource) in Practice: Benchmarks, Case Studies and Playbooks Understanding Technology Adoption in Clinical Trials In the ever-evolving landscape of clinical research, the integration of innovative technologies is essential for the successful execution of clinical trials. Understanding the…

Read More “Technology Adoption Curves (AI, DCT, eSource) in Practice: Benchmarks, Case Studies and Playbooks” »

High-Impact Technology Adoption Curves (AI, DCT, eSource) Strategies That Protect Trial Timelines and Margins High-Impact Technology Adoption Curves (AI, DCT, eSource) Strategies That Protect Trial Timelines and Margins Understanding Patient Enrollment in Clinical Trials: The Foundation for Effective Technology Adoption Patient enrollment in clinical trials serves as a critical element of the drug development process,…

Read More “High-Impact Technology Adoption Curves (AI, DCT, eSource) Strategies That Protect Trial Timelines and Margins” »

Linking Technology Adoption Curves (AI, DCT, eSource) to Market Access, HTA and Payer Expectations The clinical research landscape is rapidly evolving. As professionals in clinical operations, regulatory affairs, and medical affairs comprehend the significance of adopting emerging technologies in clinical trials, understanding technology adoption curves becomes crucial. This article explores how AI, decentralized trials (DCT),…

Read More “Linking Technology Adoption Curves (AI, DCT, eSource) to Market Access, HTA and Payer Expectations” »